| 000 | 01857 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250514222758.0 | ||
| 264 | 0 | _c20050516 | |
| 008 | 200505s 0 0 eng d | ||
| 022 | _a0092-8674 | ||
| 024 | 7 |
_a10.1016/j.cell.2004.12.040 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBeuvink, Iwan | |
| 245 | 0 | 0 |
_aThe mTOR inhibitor RAD001 sensitizes tumor cells to DNA-damaged induced apoptosis through inhibition of p21 translation. _h[electronic resource] |
| 260 |
_bCell _cMar 2005 |
||
| 300 |
_a747-59 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aCell Cycle Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aCisplatin _xpharmacology |
| 650 | 0 | 4 | _aCyclin-Dependent Kinase Inhibitor p21 |
| 650 | 0 | 4 |
_aDNA Damage _xdrug effects |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aEverolimus |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aPolyribosomes _xdrug effects |
| 650 | 0 | 4 |
_aProtein Biosynthesis _xdrug effects |
| 650 | 0 | 4 |
_aProtein Kinases _xgenetics |
| 650 | 0 | 4 |
_aRNA, Small Interfering _xgenetics |
| 650 | 0 | 4 |
_aSirolimus _xanalogs & derivatives |
| 650 | 0 | 4 | _aTOR Serine-Threonine Kinases |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xgenetics |
| 700 | 1 | _aBoulay, Anne | |
| 700 | 1 | _aFumagalli, Stefano | |
| 700 | 1 | _aZilbermann, Frederic | |
| 700 | 1 | _aRuetz, Stephan | |
| 700 | 1 | _aO'Reilly, Terence | |
| 700 | 1 | _aNatt, Francois | |
| 700 | 1 | _aHall, Jonathan | |
| 700 | 1 | _aLane, Heidi A | |
| 700 | 1 | _aThomas, George | |
| 773 | 0 |
_tCell _gvol. 120 _gno. 6 _gp. 747-59 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.cell.2004.12.040 _zAvailable from publisher's website |
| 999 |
_c15467973 _d15467973 |
||